WOBURN, Mass.--(BUSINESS WIRE)--BioTrove, Inc. today announced an agreement with OncoMethylome Sciences (Euronext: ONCO) for supply and use of BioTrove’s OpenArray™ PCR screening technology in the development of DNA gene methylation cancer biomarkers.
